Synlett 2006(1): 0101-0105  
DOI: 10.1055/s-2005-922784
LETTER
© Georg Thieme Verlag Stuttgart · New York

Efficient Parallel Resolution of Racemic Evans’ Oxazolidinones Using quasi-Enantiomeric Profens

Gregory S. Coumbaridesa, Marco Dingjana, Jason Eames*a, Anthony Flinnb, Majid Motevallia, Julian Northenb, Yonas Yohannesa
a Department of Chemistry, Queen Mary, University of London, Mile End Road, London, E1 4NS, UK
Fax: +44(1482)466410; e-Mail: j.eames@hull.ac.uk;
b Onyx Scientific Limited, Units 97-98, Silverbriar, Sunderland Enterprise Park East, Sunderland, SR5 2TQ, UK
Further Information

Publication History

Received 11 October 2005
Publication Date:
16 December 2005 (online)

Abstract

Racemic Evans’ oxazolidinones were efficiently resolved using a combination of quasi-enantiomeric profens. The ­levels of stereocontrol were high, giving products with predictable configurations.

1

New address: Department of Chemistry, University of Hull, Kingston upon Hull, HU6 7RX, UK.

9

Experimental Section: Representative Procedure for the Parallel Kinetic Resolution of Oxazolidinone ( rac )-1 Using quasi -Enantiomeric Profen Esters ( S )-17 and ( R )-25.
n-BuLi (0.61 mL, 2.5 M in hexane, 1.52 mmol) was added to a stirred solution of oxazolidinone (rac)-1 (0.18 g, 1.08 mmol) in THF (2 mL) at -78 °C. After stirring for 1 h, a solution of active esters (S)-17 (0.22 g, 0.55 mmol) and (R)-25 (0.20 g, 0.55 mmol) in THF (2 mL) were slowly added. The resulting solution was stirred for a further 2 h at -78 °C. The reaction was quenched with H2O (10 mL) and extracted with Et2O (2 × 20 mL). The combined organic layers were dried (over MgSO4) and evaporated under reduced pressure. The residue was purified by flash column chromatography eluting with light PE (40-60 °C)-Et2O (1:1) to give oxazolidinone syn-21 (101 mg, 49%) as a white solid and oxazolidinone syn-26 (99 mg, 52%) as a white solid.
Oxazolidinone syn-21: mp 168-170 °C; R f = 0.19 [light PE (40-60 °C)-Et2O (1:1)]; [α]D 24 +166.2 (c 1.5, CHCl3). IR (CHCl3): νmax = 1780 and 1706 (CO), 1632, 1605 and 1500 (Ar) cm-1. 1H NMR (270 MHz, CDCl3): δ = 7.64 (1 H, d, J = 7.7 Hz, CH, Ar), 7.52 (1 H, d, J = 7.7 Hz, CH, Ar), 7.35 (1 H, br s, CH, Ar), 7.30-7.05 (5 H, m, 6 × CH, Ar and Ph), 6.88 (2 H, d, J = 7.7 Hz, 2 × CH, Ar), 5.46 (1 H, dd, J = 9.2, 5.2 Hz, CHN), 5.20 (1 H, q, J = 6.9 Hz, CHCO), 4.63 (1 H, t, J = 8.9 Hz, CH AHBO), 4.05 (1 H, dd J = 8.9, 5.2 Hz, CHA H BO), 3.92 (3 H, s, CH 3, CH 3O), 1.44 (3 H, d, J = 6.9 Hz, CH 3CH). 13C NMR (100.6 MHz, CDCl3): δ = 173.3 (C=O), 157.7 (C=O), 153.1 (i-COCH3, Ar), 138.2 (i-C, Ar), 135.2 (i-C, Ar), 133.7, 129.4, 128.9, 128.5, 127.4, 127.1, 126.4, 126.0, 118.8 and 105.5 (10 × C, Ar and Ph), 69.6 (CHN), 57.9 (CH2O), 55.3 (CH3O), 43.9 (CHCO), 18.8 (CH3). MS: m/z calcd for C23H22NO4: 376.1549; found: 376.1553 [MH+].
Oxazolidinone syn-26: mp 97-99 °C; R f = 0.47 [light PE (40-60 °C)-Et2O (1:1)]; [α]D 24 -99.1 (c 0.4, CHCl3). IR (CHCl3): νmax = 1779 and 1705 (CO), 1514 (Ar) cm-1. 1H NMR (270 MHz, CDCl3): δ = 7.28-7.15 (3 H, m, 3 × CH, Ph), 7.0 (4 H, s, 4 × CH, Ar), 6.90 (2 H, d, J = 7.9 Hz, 2 × CH, Ph), 5.44 (1 H, dd, J = 9.2, 5.2 Hz, CHN), 5.09 (1 H, q, J = 6.9 Hz, CHCO), 4.63 (1 H, t, J = 9.2 Hz, CH AHBO), 4.06 (1 H, dd, J = 8.9, 5.2 Hz, CHA H BO), 2.43 (2 H, d, J = 7.4 Hz, CH 2CHCH3), 1.89-1.79 [1 H, m, CH(CH3)2], 1.38 (3 H, d, J = 6.9 Hz, CH 3CHCO), 0.90 [6 H, d, J = 6.7 Hz, 2 × CH3, (CH 3)2CH)]. 13C NMR (100.6 MHz, CDCl3): δ = 174.3 (C=O), 153.3 (C=O), 140.7, 139.4 and 137.4 (3 × i-C, Ar and Ph), 129.3, 129.2, 128.7, 127.9, 125.8 (5 × CH, Ar and Ph), 69.7 (NCH), 58.1 (CH2O), 45.1 (CHCO), 42.7 (CH2Ar), 30.2 [CH(CH3)2], 22.4 [CH(CH3)2], 19.4 [CH3CH]. MS: m/z calcd for C22H26NO3: 352.1913; found: 352.1909 [MH+].).